Login to Your Account

Regeneron, Aventis In Potential $485M Alliance On VEGF Trap

By Randall Osborne

Tuesday, September 9, 2003
Regeneron Inc.'s fortunes - and its stock - experienced an upswing Monday with the disclosure of a potential $485 million deal focused on its VEGF Trap product candidate with Aventis SA. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription